A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Peking University Third Hospital
Peking University Third Hospital
National Institutes of Health Clinical Center (CC)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
National Institutes of Health Clinical Center (CC)
National Health Research Institutes, Taiwan
University of Utah
AstraZeneca
Avera McKennan Hospital & University Health Center
Imperial College London
University of Wisconsin, Madison
AstraZeneca
Fondazione del Piemonte per l'Oncologia
Catholic University of the Sacred Heart
WellSpan Health
AstraZeneca
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Carevive Systems, Inc.
Hospices Civils de Lyon
M.D. Anderson Cancer Center
A2 Biotherapeutics Inc.
University Hospital Tuebingen
Abramson Cancer Center at Penn Medicine
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
iOMEDICO AG
University of Nebraska
EXoPERT
Adela, Inc
Natera, Inc.
Mayo Clinic
Dysplasia Diagnostics Limited
University of Southern California
University Health Network, Toronto
Allarity Therapeutics
Massive Bio, Inc.
Wake Forest University Health Sciences
University of Washington
McGill University
Massachusetts General Hospital
Azienda USL Reggio Emilia - IRCCS
University of Alabama at Birmingham
Sun Yat-sen University
Complejo Hospitalario Universitario Insular Materno Infantil
Masonic Cancer Center, University of Minnesota
Women's Hospital School Of Medicine Zhejiang University
Imperial College Healthcare NHS Trust
Yonsei University
McGill University
Peking University Third Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Universitaire Ziekenhuizen KU Leuven